Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)
China · Delayed Price · Currency is CNY 89.34
+0.54 (0.61%)
Jun 24, 2026, 3:00 PM CST
SHA:688016 Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, SHA:688016 stock has a consensus rating of "Buy" and an average price target of ¥127.25. The average 1-year stock price forecast is 42.43% higher than the current stock price, while the lowest is ¥94.00 (+5.22%) and the highest is ¥150.00 (+67.90%).
Price Target: ¥127.25 (+42.43%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SHA:688016 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 4 | 5 | 5 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 6 | 7 | 7 | 6 |
Financial Forecast
Revenue This Year
1.70B
from 1.35B
Increased by 25.56%
Revenue Next Year
1.81B
from 1.70B
Increased by 7.00%
EPS This Year
4.69
from 4.14
Increased by 13.34%
EPS Next Year
5.45
from 4.69
Increased by 16.19%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.4B | ||
| Avg | 1.7B | ||
| Low | 1.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 75.6% | ||
| Avg | 25.6% | ||
| Low | 14.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 4.69 | ||
| Avg | 4.69 | ||
| Low | 4.69 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 13.3% | ||
| Avg | 13.3% | ||
| Low | 13.3% |